CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I/II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772) in Children With Refractory Solid Tumors or Refractory Leukemias

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01445080
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:50.251334+00:00
Published At: 2021-02-02T00:00:00+00:00
Record Updated At: 2021-02-02
Results Posted At: 2021-02-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Blastic Phase", "Childhood Acute Promyelocytic Leukemia With PML-RARA", "Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Childhood Solid Neoplasm", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Juvenile Myelomonocytic Leukemia", "Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-02"
protocolSection.identificationModule.nctId: "NCT01445080"
protocolSection.identificationModule.officialTitle: "A Phase I/II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772) in Children With Refractory Solid Tumors or Refractory Leukemias"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-02-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.